FDA Investigator Jennifer M Menendez

Jennifer M Menendez has inspections in 2 countries as of 29 Sep 2023. Jennifer M Menendez has collaborated with a combinined 2795 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
126
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100000129
Country:
United States of America
Co-Investigator(s):
Aaron F Coleman, Adam R Cooke, Ademola O Daramola, Alexander B Anderson, Althea A Williams, Alysia M Salonia, Amber G Wardwell, Ana Delp Cintron, Ana P Barido, Anabel Veiga, Angela E Glenn, Angela F Orozco, Ariel Cruz Figueroa, Barbara T Carmichael, Benita C Okeke, Bill Tacket, Jr, Bonita S Chester, Brunilda Torres, Burnell M Henry, Caroline Strasinger, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Cheryl A Clausen, Chiaochun J Wang, Christopher T Smith, Chyla T Hunter, Clara E Santiago, Cody J Alley, Craig A Garmendia, Dandan Wang, PhD, Dawn M Mccabe, Dennis Cantellops Paite, Diana Ramirez, Dianiris C Ayala, Dionne D Arline, Douglas L Page, Dyvette Arline, Edwards, Edwin J Gorney, Eric R Holm, Ethan P Stegman, Fabian Nchaparro Rodriguez, Frances M Rivera, Frances M Rivera Rosario, Frank J Marciniak, Frederick L Fricke, Gabriel E Muniz, Gale E Ryan, Gerard D Difiore, Gerard Difiore, German Rivera, Gina Eng, Harshal H Desai, Harshal J Desai, Heather M Bullock, Hecter Jcolon Torres, Hector J Colon Torres, Hunt, Israel Juarbe, J'maica J Hunter, James To Neal, Jana L Caylor, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer Lalama, Jennifer M Donzanti, Jennifer M Melendez, Jessica L Pressley, Joanne E King, Joe X Phillips, Jogy George, John B Crowe, John J Bernal, Jordan M Williamson, Jorge L Lajara, Jose Alopez Rubet, Jose R Rodriguez, Jose Velez, Joseph X Phillips, Justin H Erickson, Karen M Rodriguez, Karl D Hezel, Kathleen M Sinninger, Kayla V Sprague, Kendra A Biddick, Kevin T Nguyen, Ladislav Kermet, LCDR Angelica M Chica, LCDR Randall L Morris, Leslie A Cartmill, Leslie A Jackanicz, Leyden Guerrero, Libia M Lugo, Lidia C Diaz, Lillian Mcolon Mcknight, Lisa A Warner, Lissette Paiz, LT Richard A Lyght, LT Tamara J Henderson, Luz I Collado, Marc Balzarini, Maria V Price, Marie F Morin, Marinee Flores Marrero, Martrice A Packer, Mary F Bodick, Matthew F Duff, Mendoza, Meredith P Soehl, Investigator, Merril E Racke, Merril R Racke, Michael C Lombardi, Michael F Mccoy, Miguel A Martinez, Neimar Lopez Martinez, Ni A Khin, MD, Nicole E Knowlton, Nicole M Bell, Noreen Muniz, Omayra Nrodriguez Ruiz, Ormond, Pablo Alcantara, Patrick E Gainer, Paul A Licata, Rachel A Gomez, Rachel A Peters, Raymond A Lyn, Jr, Rebecca Rodriguez, Rina Bhikha, Robert C Coleman, Robert D Tollefsen, Robert Sharpnack, Rodney W Lenger, Ronald Ifraimov, Ronan F King, Roy R Rinc, Sally Gopaul, Salvatore N Randazzo, Samantha E Cleek, Sarah E Mcmullen, Sarah Ibrahim, Saundrea A Munroe, Sharon Giamberini, Sherbet L Samuels, Sheri L Stephenson, Simone E Pitts, Sonia M Monges, Stacey A Meyer, State Agency, Stephanie D Crockett, Susan M Corrales, Susan M Turcovski, Suzanne N Vallez, Teresa I Navas, Thomas J Arista, Timothy A Tennell, Victor Sanivli, Victor Spanioli, Vivin George

Jennifer M Menendez's Documents

Publish Date Document Type Title
September, 2001 EIR Larry I. Gilderman, D.O. - EIR, 2001-09-28
April, 2005 FDA 483 Response Weiner, Gilbert R. - Form 483R, 2005-04-07
April, 2005 EIR Weiner, Gilbert R. - EIR, 2005-04-07
September, 2001 FDA 483 Response Larry I. Gilderman, D.O. - Form 483R, 2001-10-03
May, 2001 FDA 483 Watson Laboratories, Inc. - Form 483, 2001-05-18
December, 2004 FDA 483 Custom Manufacturing Corporation - Form 483, 2004-12-09
April, 2002 FDA 483 Jeffrey B. Rosen, M.D. - Form 483, 2002-04-30
April, 2002 EIR Jeffrey B. Rosen, M.D. - EIR, 2002-04-30
October, 2003 EIR P and L Development of New York Corporation - EIR, 2003-10-07
November, 2002 EIR Global Source Management & Consulting, Inc - EIR, 2002-11-13
April, 2003 EIR Azopharma Contract Services, Inc. - EIR, 2003-04-25
April, 2000 FDA 483 Cosmetic Corporation of America - Form 483, 2000-04-27
June, 2002 FDA 483 Response SFBC International Inc. - Form 483R, 2002-06-27
May, 2005 FDA 483 SFBC International Inc. - Form 483, 2005-05-02
July, 2003 FDA 483 Noven Pharmaceuticals, Inc. - Form 483, 2003-06-25
February, 2007 EIR Howard I. Schwartz, M.D. - EIR, 2007-02-02
April, 2006 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2006-04-18
April, 2005 FDA 483 Weiner, Gilbert R. - Form 483, 2005-03-16
November, 2002 EIR Eisdorfer, Carl - EIR, 2002-12-04
April, 2000 FDA 483 Response Cosmetic Corporation of America - Form 483R, 2000-06-23
September, 2003 FDA 483 Vibranta, Inc. - Form 483, 2003-09-24
September, 2001 FDA 483 University Clinical Research - Form 483, 2001-09-28
November, 2002 EIR Richard Douyon, MD - EIR, 2002-12-01
May, 2005 EIR SFBC International Inc. - EIR, 2005-05-02
May, 2001 EIR Watson Laboratories, Inc. - EIR, 2001-05-18
December, 2001 EIR Global Source Management & Consulting, Inc - EIR, 2001-12-20
September, 2003 EIR Vibranta, Inc. - EIR, 2003-09-24
June, 2002 FDA 483 SFBC International Inc. - Form 483, 2002-06-24
May, 2001 FDA 483 Response Watson Laboratories, Inc. - Form 483R, 2001-08-13
June, 2002 EIR SFBC International Inc. - EIR, 2002-06-24

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more